Can nature lead scientists to better treatments for Alzheimer’s disease? A recent study highlights the aloe vera plant and indicates that one of its compounds may hold promising potential to slow the progression of this neurodegenerative disease, which is the most common form of dementia.
A natural compound under a microscope
The research was conducted by a team from Hassan II University in Casablanca, Morocco, and focused on a compound known as “beta-sitosterol,” a plant substance found in aloe vera leaves.
Aloe vera has been used for centuries in traditional medicine to treat skin infections, improve digestion, and support immunity, but scientific evidence about some of these benefits is still mixed.
However, the new study opens a different door, which is the possibility of benefiting from its compounds in the field of neurological diseases.
Completely digital study
The researchers relied on a methodology known as a “computational study,” that is, using computer models to simulate how aloe vera compounds interact with enzymes thought to play a role in the development of Alzheimer’s disease.
Although the study did not include laboratory or clinical experiments on humans, it represents a first step to identifying potential treatment paths that deserve further research.
The results indicate that beta-sitosterol showed a high ability to bind to two main enzymes:
- Acetylcholinesterase
- Butyrylcholinesterase
Why are these enzymes important?
The disease is associated with low levels of acetylcholine, a neurotransmitter essential for learning and memory processes. The enzymes AChE and BChE break down this neurotransmitter, causing its levels to decline.
Therefore, inhibiting the activity of these two enzymes may help maintain a greater amount of acetylcholine in the brain, a principle on which some medications currently used to treat symptoms rely.
According to the simulation results, “beta-sitosterol” obtained the highest degree of binding to the two enzymes, indicating its potential effectiveness in reducing their activity.
Assessing potential for drug conversion
The research did not stop at the binding capacity, but the compound underwent an analysis known as ADMET, which is an abbreviation for factors:
- Absorption
- distribution
- Metabolism
- Output
- Toxicity
This analysis aims to evaluate the suitability of the compound to be a safe and effective medicine within the body. The results showed good performance for both “beta-sitosterol” and another compound, “succinic acid,” which reinforces the need for laboratory and clinical tests in the future.
Challenges
The researchers stress that there is still a long way to go, as the current results are based on computer simulations only, and cannot be considered conclusive evidence of therapeutic effectiveness.
Alzheimer’s disease currently affects more than 55 million people around the world, with the number expected to rise to 138 million by 2050, as the population ages. It is the leading cause of dementia globally.
Despite the increasing progress in understanding the mechanisms of the disease and the risk factors associated with it, its precise causes are still not fully understood, which makes developing a cure a complex scientific challenge.
New research horizons
This study adds the aloe vera plant to the list of natural sources that may contribute to the development of future treatments, along with other research examining blood pressure medications and some cancer medications to repurpose them into treating Alzheimer’s.
The researchers stress that the digital approach represents a promising tool to accelerate the discovery of new compounds, but it remains a first step that requires careful laboratory and clinical trials before moving on to any actual therapeutic use.
While final answers are still far away, scientists continue to search for new keys to understanding this complex disease. Perhaps nature hides one of the solutions in the leaves of a simple plant.